• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用固相萃取和紫外检测的高效液相色谱法测定患者血浆中氯沙坦的浓度。

Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.

作者信息

Yeung P K, Jamieson A, Smith G J, Fice D, Pollak P T

机构信息

Pharmacokinetics and Metabolism Laboratory, College of Pharmacy, Faculty of Health Professions, Dalhousie University, Halifax, NS, Canada.

出版信息

Int J Pharm. 2000 Aug 25;204(1-2):17-22. doi: 10.1016/s0378-5173(00)00453-1.

DOI:10.1016/s0378-5173(00)00453-1
PMID:11011981
Abstract

PURPOSE

To establish a HPLC assay for plasma losartan and its active metabolite EXP3174 to facilitate clinical pharmacokinetic studies.

METHODS

the HPLC system consisted of a 250 x 2 mm i.d. C18 reversed phase column preceded by a 4 x 4 mm guard column, a UV detector set at 254 nm, and an integrator. The mobile phase was a mixture of 0.01 M ammonium phosphate: acetonitrile: methanol (6:3:1) containing 0.02 % sodium azide and 0.04% TEA, with pH adjusted to 3.2. The system was operated isocratically at ambient temperature at a flow rate of 0.3 ml/min. Losartan and its active metabolite EXP3174 were extracted from plasma using C2 bonded silica gel standard solid phase extraction.

RESULTS

recoveries of losartan and EXP3174 from plasma were greater than 70%. Using 0.5 ml of plasma sample, standard curves were linear from 10 to 300 ng/ml (r2 = 0.996 and 0.997 for losartan and EXP 3174, respectively). Sensitivity of the assay was < 10 ng/ml. Intra-and inter-assay variations were < 10 and 15%. respectively. The assay has been successfully applied to measuring plasma concentrations of losartan and EXP3174 in patients receiving a daily dose of losartan (50-100 mg).

CONCLUSION

The HPLC assay has adequate sensitivity, reproducibility, and specificity for clinical pharmacokinetic studies.

摘要

目的

建立一种用于测定血浆中氯沙坦及其活性代谢产物EXP3174的高效液相色谱法,以促进临床药代动力学研究。

方法

高效液相色谱系统由一根内径为250×2mm的C18反相柱和一根4×4mm的保护柱组成,配备一个设定在254nm的紫外检测器和一个积分仪。流动相为含有0.02%叠氮化钠和0.04%三乙胺的0.01M磷酸铵:乙腈:甲醇(6:3:1)混合物,pH值调至3.2。该系统在室温下等度运行,流速为0.3ml/min。氯沙坦及其活性代谢产物EXP3174采用C2键合硅胶标准固相萃取法从血浆中提取。

结果

氯沙坦和EXP3174从血浆中的回收率大于70%。使用0.5ml血浆样品,标准曲线在10至300ng/ml范围内呈线性(氯沙坦和EXP3174的r2分别为0.996和0.997)。该测定法的灵敏度<10ng/ml。批内和批间变异分别<10%和15%。该测定法已成功应用于测定每日服用氯沙坦(50 - 100mg)患者血浆中氯沙坦和EXP3174的浓度。

结论

该高效液相色谱法对临床药代动力学研究具有足够的灵敏度、重现性和特异性。

相似文献

1
Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.采用固相萃取和紫外检测的高效液相色谱法测定患者血浆中氯沙坦的浓度。
Int J Pharm. 2000 Aug 25;204(1-2):17-22. doi: 10.1016/s0378-5173(00)00453-1.
2
Rapid determination of losartan and losartan acid in human plasma by multiplexed LC-MS/MS.采用多重 LC-MS/MS 法快速测定人血浆中的氯沙坦及其酸形式。
J Sep Sci. 2009 Oct;32(20):3388-94. doi: 10.1002/jssc.200900287.
3
Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.利用液相色谱/串联质谱法同时测定人血浆和尿液中的氯沙坦和EXP3174。
J Pharm Biomed Anal. 2003 Sep 15;33(1):73-84. doi: 10.1016/s0731-7085(03)00348-0.
4
Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-format-based solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry.通过基于96孔板的全自动固相萃取和液相色谱-负电喷雾串联质谱法同时测定血浆中的氯沙坦、EXP-3174和氢氯噻嗪。
Anal Bioanal Chem. 2007 Jan;387(2):593-601. doi: 10.1007/s00216-006-0990-4. Epub 2006 Nov 21.
5
Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.采用液相色谱-电喷雾电离串联质谱法同时测定人血浆中氯沙坦及其主要代谢物EXP-3174的方法。
J Chromatogr B Biomed Sci Appl. 1999 Nov 12;734(2):325-30. doi: 10.1016/s0378-4347(99)00358-8.
6
HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.
J Pharm Biomed Anal. 1998 Jan;16(5):863-73. doi: 10.1016/s0731-7085(97)00128-3.
7
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):374-8. doi: 10.1016/s0378-4347(97)00489-1.
8
Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.用高效液相色谱法同时测定人血浆和尿液中新型血管紧张素II受体阻断剂氯沙坦及其代谢物。
J Chromatogr. 1992 Jan 17;573(2):295-301. doi: 10.1016/0378-4347(92)80132-a.
9
Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection.通过将人尿液直接注入具有荧光检测的柱切换液相色谱系统来测定氯沙坦、替米沙坦和缬沙坦。
J Pharm Biomed Anal. 2009 Sep 8;50(2):194-9. doi: 10.1016/j.jpba.2009.04.015. Epub 2009 Apr 19.
10
HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies.高效液相色谱法测定人血浆中的厄贝沙坦:其在药代动力学研究中的应用
Biomed Chromatogr. 2009 Jun;23(6):568-72. doi: 10.1002/bmc.1154.

引用本文的文献

1
Voluntary Oral Administration of Losartan in Rats.氯沙坦在大鼠中的自愿口服给药。
J Am Assoc Lab Anim Sci. 2015 Sep;54(5):549-56.
2
RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form.反相高效液相色谱法测定复方制剂中氯沙坦钾和雷米普利的含量
Indian J Pharm Sci. 2010 Jan;72(1):108-11. doi: 10.4103/0250-474X.62243.
3
Pharmacokinetics of Losartan and its Active Metabolite EXP3174 in Healthy Iranian Subjects.氯沙坦及其活性代谢物EXP3174在伊朗健康受试者中的药代动力学
Clin Drug Investig. 2004;24(10):619-23. doi: 10.2165/00044011-200424100-00008.